F.D.A. Approves 2 Sickle Cell Treatments, One Using CRISPR Gene Editingnews2023-12-09T02:22:13+00:00December 9th, 2023|The New York Times|
New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Mostnews2023-12-08T22:46:17+00:00December 8th, 2023|The New York Times|
Sickle-Cell Treatment Created With Gene Editing Wins U.K. Approvalnews2023-11-16T22:23:56+00:00November 16th, 2023|The New York Times|
Panel Tells F.D.A. That CRISPR Sickle Cell Cure Is Safe Enough for Patientsnews2023-10-31T21:21:11+00:00October 31st, 2023|The New York Times|
F.D.A. Experts Will Vote on Safety of a Cure for Sickle Cell Diseasenews2023-10-30T20:19:43+00:00October 30th, 2023|The New York Times|
A New Sickle Cell Treatment Will Change Lives — but How Many?news2023-10-30T09:01:12+00:00October 30th, 2023|The New York Times|
Targeting the Uneven Burden of Kidney Disease on Black Americansnews2022-05-17T07:01:35+00:00May 17th, 2022|The New York Times|
Family in Nigeria Lost 3 Daughters to Sickle Cell. Can They Save a Fourth?news2021-12-21T12:27:49+00:00December 21st, 2021|The New York Times|
Pioneering Gene Therapy Freed Her of Sickle Cell. Is a Cure at Hand?news2021-09-14T10:52:00+00:00September 14th, 2021|The New York Times|
